✦ LIBER ✦

The Value of Patient-Centred Registries in Phase IV Drug Surveillance

✍ Scribed by McNeil, John J.; Piccenna, Loretta; Ronaldson, Kathlyn; Ioannides-Demos, Lisa L.

Book ID: 121373919
Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 129 KB
Volume: 24
Category: Article
ISSN: 1178-2595
DOI: 10.1007/BF03256826

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Value of surveillance cultures in the ma

Value of surveillance cultures in the management of neutropenic patients

✍ M. A. Daw; P. Munnelly; S. R. McCann; P. A. Daly; F. R. Falkiner; C. T. Keane 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 602 KB

PHP3 THE VALUE OF PATIENT PERSPECTIVES I

PHP3 THE VALUE OF PATIENT PERSPECTIVES IN THE DRUG DEVELOPMENT LIFECYCLE

✍ J Versnel; J Watch; O Jack; K Sparrowhawk 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Value of Brush Cytology in the Surveilla

Value of Brush Cytology in the Surveillance of Patients with Primary Sclerosing Cholangitis

✍ Hassan Abou-Rebyeh; Hussain Al-Abadi; Zeynep Al-Khalili; Wilfried Veltzke-Schlie 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 49 KB

1809 THE NATURAL HISTORY OF RENAL FUNCTI

1809 THE NATURAL HISTORY OF RENAL FUNCTIONAL DECLINE IN PATIENTS UNDERGOING SURVEILLANCE IN THE DISSRM (DELAYED INTERVENTION AND SURVEILLANCE FOR SMALL RENAL MASSES) REGISTRY

✍ Castaneda, Crystal; Leigh, Natasha; Pierorazio, Phillip; Allaf, Mohamad; Ahn, Je 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 112 KB

Recommendations for Phase IV Studies in

Recommendations for Phase IV Studies in the Development of Lipid-Lowering Drugs

✍ R.E. Gregg 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 40 KB

The added value of centres of expertise

The added value of centres of expertise for rare disease patients in Europe

✍ Anna A Kole, Yann le Cam 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 176 KB